Holen Sie sich die Stockscreener-App
25.66
3.14%
0.78
Handel nachbörslich:
25.30
-0.36
-1.40%
Schlusskurs vom Vortag:
$24.88
Offen:
$24.9
24-Stunden-Volumen:
613.98K
Relative Volume:
0.71
Marktkapitalisierung:
$2.89B
Einnahmen:
$14.09M
Nettoeinkommen (Verlust:
$-176.94M
KGV:
-11.93
EPS:
-2.15
Netto-Cashflow:
$-141.24M
1W Leistung:
+7.14%
1M Leistung:
+18.47%
6M Leistung:
+19.35%
1J Leistung:
+60.17%
1-Tages-Spanne:
$24.41
$25.74
1-Wochen-Bereich:
$23.70
$25.74
52-Wochen-Spanne:
$14.06
$27.29
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Firmenname
Newamsterdam Pharma Company Nv
Sektor
Branche
Telefon
35 206 2971
Adresse
GOOIMEER 2-35, NARRDEN
Vergleichen Sie NAMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
25.66 | 2.77B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-17 | Eingeleitet | Goldman | Neutral |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-06-10 | Eingeleitet | Stifel | Buy |
| 2025-06-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-15 | Eingeleitet | TD Cowen | Buy |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-18 | Eingeleitet | Guggenheim | Buy |
| 2024-01-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-30 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten
NewAmsterdam Pharma Company N.V.’s volatility index tracking explainedMarket Trend Review & Expert-Curated Trade Recommendations - Newser
Does NewAmsterdam Pharma Company N.V. have pricing power2025 Top Gainers & High Accuracy Investment Signals - khodrobank.com
Published on: 2025-09-03 09:14:15 - Newser
Does NewAmsterdam Pharma Company N.V. Equity Warrant align with a passive investing strategyMarket Sentiment Report & Daily Entry Point Alerts - khodrobank.com
What to expect from NewAmsterdam Pharma Company N.V. Equity Warrant in the next 30 daysMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Can swing trading help recover from NewAmsterdam Pharma Company N.V. Equity Warrant lossesEarnings Summary Report & Breakout Confirmation Alerts - Newser
How to build a custom watchlist for NewAmsterdam Pharma Company N.V. Equity WarrantQuarterly Profit Report & Safe Capital Preservation Plans - Newser
Using RSI to spot recovery in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser
Can trapped investors hope for a rebound in NewAmsterdam Pharma Company N.V.Market Performance Report & Daily Market Momentum Tracking - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
Applying Elliott Wave Theory to NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Sector ETF performance correlation with NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Growth Summary & Stepwise Trade Execution Plans - Newser
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V.July 2025 Decliners & Growth Oriented Trading Recommendations - Newser
Technical signs of recovery in NewAmsterdam Pharma Company N.V. Equity WarrantAnalyst Downgrade & Safe Entry Zone Identification - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant a momentum stockVolume Spike & Real-Time Stock Movement Alerts - khodrobank.com
Published on: 2025-09-03 00:34:38 - Newser
A | Is NewAmsterdam Pharma Company N.V. stock good for income investorsWeekly Trading Summary & Verified Technical Signals - khodrobank.com
Analyzing drawdowns of NewAmsterdam Pharma Company N.V. with statistical toolsJuly 2025 Patterns & Technical Confirmation Trade Alerts - Newser
Using Ichimoku Cloud for NewAmsterdam Pharma Company N.V. Equity Warrant technicalsJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Will NewAmsterdam Pharma Company N.V. Equity Warrant benefit from macro trendsEarnings Beat & High Accuracy Swing Trade Signals - Newser
Real time breakdown of NewAmsterdam Pharma Company N.V. stock performanceMarket Activity Summary & Fast Exit/Entry Strategy Plans - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant forming higher highs and higher lowsWeekly Investment Summary & Free AI Powered Buy and Sell Recommendations - khodrobank.com
Sector ETF performance correlation with NewAmsterdam Pharma Company N.V.July 2025 PostEarnings & Detailed Earnings Play Strategies - Newser
How to monitor NewAmsterdam Pharma Company N.V. with trend dashboards2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
What is NewAmsterdam Pharma Company N.V. Equity Warrant s debt to equity ratio2025 Earnings Surprises & Accurate Buy Signal Notifications - kpenews.com
NewAmsterdam Pharma Highlights Progress in Obicetrapib Trials - TipRanks
Published on: 2025-09-02 05:29:56 - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant a potential multi baggerEarnings Growth Report & Consistent Growth Stock Picks - khodrobank.com
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V.Weekly Trading Summary & AI Optimized Trade Strategies - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock entering bullish territoryWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
Visual analytics tools that track NewAmsterdam Pharma Company N.V. performancePortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V. Equity WarrantTrade Exit Summary & Short-Term High Return Ideas - Newser
Is NewAmsterdam Pharma Company N.V. a momentum stockJuly 2025 Institutional & Weekly High Conviction Trade Ideas - khodrobank.com
What’s NewAmsterdam Pharma Company N.V. Equity Warrant’s historical returnJuly 2025 EndofMonth & Verified Entry Point Signals - khodrobank.com
Published on: 2025-09-02 01:54:57 - خودرو بانک
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V.Risk Management & High Conviction Trade Alerts - Newser
Is NewAmsterdam Pharma Company N.V. trending in predictive chart modelsWeekly Investment Recap & Technical Analysis for Trade Confirmation - Newser
Using R and stats models for NewAmsterdam Pharma Company N.V. forecastingJuly 2025 Opening Moves & Pattern Based Trade Signal System - Newser
Short Covering May Lift NewAmsterdam Pharma Company N.V. in Near TermJuly 2025 Closing Moves & AI Forecast Swing Trade Picks - beatles.ru
NewAmsterdam Pharma Company N.V. Equity Warrant Recovery Hinges on Volume BreakoutJuly 2025 Intraday Action & High Win Rate Trade Tips - beatles.ru
Is NewAmsterdam Pharma Company N.V. Equity Warrant a candidate for recovery playQuarterly Portfolio Review & High Return Trade Guides - Newser
Live market analysis of NewAmsterdam Pharma Company N.V.July 2025 Movers & Real-Time Volume Analysis Alerts - Newser
Can momentum traders help lift NewAmsterdam Pharma Company N.V.2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Newamsterdam Pharma Company Nv-Aktie (NAMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer |
Aug 25 '25 |
Sale |
24.86 |
8,269 |
205,567 |
15,000 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):